Trial Profile
Darbepoetin Alfa in Patients With Chronic Lymphocytic Leukemia and Comorbidity
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary) ; Fludarabine (Primary)
- Indications Anaemia; Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 25 Aug 2006 New trial record.